Conference Venue –
Örebro Concert Hall
Örebro concert hall was built between 1930 and 1932 as a home for both the city library and concert activities. It was inaugurated on 2 April 1932 by Prince Eugen. It is located at Fabriksgatan next to Svartån in central Örebro. Until 1981, when the library moved to a new building on Näbbtorgsgatan, the building was home to both concert activities and the city library. Today, the concert hall is home to the local concert music in Örebro and the Swedish Chamber Orchestra, which has 38 full-time musicians (2009). The house also hosts hired events and other types of temporary arrangements.
Conference Program
All oral presentations will be in Concert hall auditorium.
Poster session rooms are noted in the program.
Thursday, Sept 5th, 2024
14:00- 21.00 ARRIVAL & REGISTRATION at Örebro Concert Hall.
14.30-16:00 DPSG BOARD MEETING
16.15-16.30 Music – Swedish Chamber orchestra and Welcome by concerthall
16:45-17:30 WELCOME: Concert Hall (Auditorium)
Chairs: Helena Backman, Ewa Wender-Ożegowska Research director for Region Örebro County Prof Mats G Karlsson and Dean of Örebro University; Prof Mia von Euler.
17:30-19:00 AID systems during pregnancy- HANDS-ON Concert Hall (Auditorium)
Chairs: Denice Feig, Rosa Corcoy
17:30-17:50 Helen Murphy: CamAPS FX
17:50-18:10 Lois Donovan: Tandem Control IQ
18:10-18:30 Katrien Benhalima: Medtronic Minimed 780G
18:30-19:00 Discussion
🍽 19.30-23.00 MINGEL DINNER and DEBATE in the Theatre Foyer
19:30-23:00 DINNER and DEBATE Concert hall (Foyer)
21:00-22:00 DEBATE Do the benefits of diagnosing and treating GDM outweigh the harms?
Chair: Christina Vinter
Pro: David Mc Intyre (20 min)
Contra: Claire L. Meek (20 min)
Friday, Sept 6th, 2024
08:30-09:00
KEYNOTE LECTURE 1:
Chair: Robert Lindsey
Fidelma Dunne: Metformin in early GDM and type 2 diabetes during pregnancy (results from EMERGE and MOMPOD trials)
09:00-10:30
ORAL PRESENTATIONS │ SESSION 1
Chairs: Lilian Mendoza; Dorte Moller Jensen
OP 01 The effect of a reduced energy diet upon maternal weight and pregnancy outcomes in women with gestational diabetes: the DiGest trial : Kusinski L., Jones D., Atta N., Turner E., Oude Griep L., Rennie R., De Rolfe Lucia E., Murphy H., Taylor R., Meek C.
OP 02 The function of 1,5-anhydroglucitol in assessing beta-cell and glucose intolerance in women with gestational diabetes: Quansah D., Jiménez-Sánchez C., Maechler P., Puder J.
OP 03 Oral antihyperglycemic agents versus insulin for gestational diabetes – a randomised controlled trial: Rademaker D., de Wit L., Duijnhoven R., Voormolen D., Siegelaar S., Akerboom B. et.al.
OP 04 LGA fetus in gestational diabetes: diagnostic accuracy and prediction of adverse outcome at birth: Ottanelli S., Vannuccini S., Biagiotti C. , Zullino S., Rambaldi M.P., Serena C., Simeone S., Bruscoli G, Angeli L, Mecacci F.
OP 05 Extracellular vesicle-associated microrna mir-515-5p secreted from adipose tissue regulates placental glucose uptake and pro-inflammatory environment, leading to increased fetal growth in gestational diabetes mellitus: Jayabalan N., Nair S., Lai A., Scholz-Romero K., Razo-Azamar M., Lim R., Guanzon D., McIntyre D., Lappas M., Salomon C.
OP 06 Metformin treatment during pregnancy does not negatively impact placental mitochondrial function: Calloway E., Higgins L., Myers J., Desforges M
10:30-11:00
☕ COFFEE BREAK
11:00-12:00
POSTER PRESENTATIONS │
PARALLEL SESSION 1 – Theme I │ GDM1 (Poster room 1- Repsalen)
Chairs: Kristina Renault, Helena Backman
PP 01 The efficacy of perinatal measures to prevent and diagnose neonatal hypoglycaemia after gestational diabetes: maternal and neonatal continuous glucose monitoring profiles from the digest trial: Jones D., Thomson L., Kusinski L., Beardsall K., Meek C.
PP 02 Maternal chronic hypertension is associated with early-pregnancy central adiposity, insulin resistance, and high rates of early- and late-onset GDM – a Finnish population-based study: Kultalahti H., Rönö K., Koistinen H., Klemetti M.
PP 03 Improving the diagnosis of gestational diabetes: effect of enhanced glucose processing and HbA1c upon diagnosis and clinical outcomes : Kusinski L., Jones D., Barker P., Burling K., Halsall I., Meek C.
PP 04 Glycemic status during oral glucose tolerance test (OGTT) and materno-fetal outcomes in gestational diabetes mellitus (GDM): Madrihan L., Lemaitre M., Szczypa P., Baudoux F., Niyitegeka MF., Subtil D., Labreuche J., Vambergue A.
PP 05 Impact of early detection and treatment of hyperglycemia in pregnancy. Systematic review and meta-analysis of randomized clinical trials: García-Patterson A., Balsells M., Solà I., Corcoy R.
PP 06 Prediction of Gestational Diabetes in Obese Pregnant Women: Hopper L., Illiodromiti M., Barry E., Freeman DJ., Huda SS.
PP 07 Gestational diabetes mellitus and intrahepatic cholestasis of pregnancy – a hepaticoplacental cross-talk? : Axelsen SM., Schmidt MC., Kampmann U., Koefoed AS., Ovesen PG., H. McIntyre D., Grønbæk H., Fuglsang J.
PP 08 Eating patterns, chronotype and their relationship with metabolic health in the early postpartum in women after GDM.: Lesniara-Stachon A., Montemayor MT, Collet TH2,3, Magali A., Quansah D., Puder J.
PP 09 Brain responses to food cue viewing in women during pregnancy and their relationship with metabolic health. An observational cohort: The FoodyBrain Study: Lesniara Stachon A., Pittet L., Quansah D., Schenk S., Montemayor MT., Murray M., Toepel U., Retsa Ch., Puder J.
PP 10 Abnormal glucose values at the various OGTT time points and neonatal outcomes in pregnancies complicated by gestational diabetes mellitus.: Athanasiadou K., Paschou S., Vasileiou V., Kanouta F., Mitropoulou M., Antsaklis P., Theodora M., Psaltopoulou T., Goulis D., Daskalakis G., Anastasiou E.
PARALLELL SESSION 1
Theme II │PG-DM I (Poster room II- Wirensalen)
Chairs: Eleanor Scott, Pawel Gutaj
PP 11 Hemoglobin A1c Trajectories During Pregnancy and Adverse Outcomes in Women with Type 2 Diabetes: A Danish National Population-based Cohort Study: Koefoed A., Knorr S., Fuglsang J., Leth-Møller M., Hulman A., Jensen DM., Andersen LLT., Rosbach E., Damm P., Mathiesen ER., Sørensen A., Christensen T., McIntyre D., Ovesen PG.,Kampmann U.
PP 12 Advanced Hybrid Closed-Loop system during breastfeeding in women with type 1 diabetes: Giuliani C, Bitterman O. Napoli A.
PP 13 Development of a scale to evaluate fear of hyperglycemia in pregnancy in women with type 1 diabetes: Gu J., Dunlop A., Chaput K., Donovan L.
PP 14 Findings from glucose monitoring among women diagnosed with type 2 diabetes mellitus during pregnancy: Monroy G., Capdevila L., Rames M., Torrecillas A., Esteban R., Hernandez M.
PP 15 Time in Tight Range in pregnant women with type 1 diabetes: are stricter targets achievable with hybrid closed loop systems?:Bitterman O., Napoli A., Giuliano C., Fresa R.
PP 16 First-trimester continuous glucose monitoring parameters in preeclamptic and normotensive patients with type 1 diabetes: Boroń D., Sibiak R., Mantaj U., Gutaj P., Kornacki J., Wender-Ożegowska E.
PP 17 Impact of birthweight on neonatal complications in babies born to patients with type 1 diabetes: Vambergue A., Gnana E., Lemaitre M., Cailliau E., Toulali F., Baudoux F., Niyitegeka MF., Subtil D.
PP 18 Medication prescribing for women with type 2 diabetes of reproductive age within primary care: a cross-sectional investigation for the PREPARED study: Forde R., Famiglietti A., Parsons J., Chua K-C., Hodgkinson A., Abiola O., Brackenridge A., Banerjee A., Chamley M.,Hunt K., Murphy H.R., Rogers H., Winkley K., Forbes A. on behalf of the PREPARED study team.
PP 19 Sensor-derived glycemic metrics in women with type 1 diabetes using insulin degludec vs. other basal insulin analogs during pregnancy – a post hoc analysis of the CopenFast trial: Søholm J., Nørgaard S., Nørgaard K., Clausen TD., Damm P., Mathiesen ER.,Ringholm L.
PP 20 Dietary fibre and glycaemic control in women with diabetes in pregnancy: a systematic review and meta-analysis: Jones D., Kyriakidou A., Cooper L., Atta N., Smith S., Turner E., Tobolska P., Petry C., Meek C.
PARALLELL SESSION 1
Theme III │ Public Health 1 (Poster room III- Berhnsalen)
Chairs: Fidelma Dunne, Karoline Kragelund
PP 21 Altered postprandial glucose metabolism and enteropancreatic hormone response during pregnancy following Roux-en-Y gastric bypass – a prospective cohort study: Stentebjerg LL., Madsen LR., Støving RK., Hartmann B., Holst JJ., Vinter CA., Juhl CB., Højlund K., Jensen DM.
PP 22 Mental health and postpartum metabolic profile in women with a recent history of gestational diabetes mellitus: Vanlaer Y., Minschart C., Van den Keybus K., Myngheer N., Maes T., De Block Ch., Van Pottelbergh I., Abrams P., Vinck W., Leuridan L., Driessens S., Billen J., Matthys Ch., Bogaerts A., Laenen A., Mathieu Ch., Benhalima K.
PP 23 Breast cancer in women with previous gestational diabetes – a nationwide register-based cohort study from Denmark: Christensen MH., Vinter CA., Olesen TB., Petersen MH., Nohr EA., Rubin KH., Andersen MS., Jensen DM.
PP 24 Associations of sleep and chronotype with mental health and well-being in women with gestational diabetes: a prospective cohort study: Montemayor MT.,Lesniara-Stachon A., Heinzer R., Collet TH., Le Dizes O., Horsch A., Quansah D., Puder J.
PP 25 Assessing the long-term risk of type 2 diabetes in women with gestational diabetes versus impaired glucose tolerance: a multi-ethnic cohort study in new zealand spanning two decades: Yu D., Wang Z., Zhao Z., Pickering K., Baker J., Cutfield R., Orr-Walker B., Sundborn G., Cai Y., Fu H., Wang C., Simmons D.
PP 26 Validation of an early prediction tool for gestational diabetes in pregnant women with obesity: Mahmoud A., Bromo D., Kicinska A., Kavanagh K., Quotah O., Flynn A., Poston L.,White SL.
PP 27 Where have all the GDMs gone? Impact of the COVID-19 pandemic on maternal characteristics and maternal and neonatal outcomes in the GDM population – cross-sectional comparison of two prospective cohorts: Malinowska-Polubiec A., Zawiejska A., Kujawa A., Zaręba-Szczudlik J., Dobrowolska-Redo A., Czajkowski K., Romejko-WolniewiczE.
PP 28 Diabetes risk perception and postpartum metabolic profile in women with prior gestational diabetes mellitus: Vanlaer Y., Minschart C., Snauwaert I., Myngheer N., Maes T., De Block C., Van Pottelbergh I.,Abrams P., Vinck W., Leuridan L., Driessens S., Billen J., Matthys C., Bogaerts A., Laenen A.,Mathieu C., Benhalima K.
PP 29 How does a gestational diabetes diagnosis affect a woman´s experience of pregnancy, childbirth, and breastfeeding? Vikner P., Sengpiel V., Backman H., Strevens H., Wikström AK., Berg M., Linden K. for the CDC4G study steering committee
PP 30 The effect of lifestyle intervention in pregnant women with obesity on self-perceived health: Poulsen MS., Aalders J, Luef BM., Jensen DM, Vinter CA.
12:00-13:15
🍽 LUNCH BREAK at the Theatre Foyer
13:15-14:45 ORAL PRESENTATIONS │ SESSION 2 (BIOMICS)
Chairs: Ulf Eriksson, Alicia Jawerbaum
OP 07 Cord blood DNA methylation as a mediator between maternal hyperglycemia and future childhood adiposity: DeLacey S., Gurra M., Bianco M., Lowe W., Hivert M., Scholtens D., Josefson J.
OP 08 The effects of a supervised exercise training program on placental cytokines and growth factors during pregnancy, and the potential role of fetal sex and overweight/obesity: Acosta-Manzano P., Flor-Alemany M., Martínez-González L. Alvarez-Cubero M., Garcia-Baena L., Van Poppel M., Aparicio V.
OP 09 Cord Blood DNA Methylation and Childhood Adiponectin: Associations with Child Adiposity and Child Dysglycemia: Bianco M., Gurra M., Scholtens D., Hivert M., Lowe W., Josefson J.
OP 10 Maternal diets enriched in olive oil prevent fetal programming of altered expression of microRNAs that target PPARs in the decidualised uteri of prepuberal offspring of diabetic rats: Gatti C., Schibert F., Taylor V., Higa R., Jawerbaum A.
OP 11 Obesity Increases Stress Granules-Associated Proteins in the First Trimester Placenta: Bandres-Meriz J., Kummer D., Heberle A., Fernandez-Silva M., Hrznjak A., Thedieck K., Khong A., Parker R.,Desoye G.
OP 12 Placental expression of glucose transporters mRNA (GLUT-1, GLUT-3 and GLUT-4) and transcriptome profiling with microarrays in pregnant patients with diabetes.: Sibiak R., Gutaj P., Mantaj U., Adamczak L., Blatkiewicz M., Rucinski M., Ewa Wender-Ozegowska.
14:45-15:15
☕ COFFEE BREAK
15:15- 15:45 KEYNOTE LECTURE 2
Chair: Claire Meek
Pat Catalano : Lifestyle Intervention in Preparation for Pregnancy (LIPP); does it improve metabolic conditioning?
15:45 -17:00 ORAL PRESENTATIONS │ SESSION 3 (Early GDM)
Chairs: Jardena Puder, David Simmons
OP 13 Ethnic differences in characteristics of women with early gestational diabetes: findings from the TOBOGM study: Yuen L., Wong V., Immanuel J., Hague B., Teede H., Cheung NW., Hibbert E., Nolan C., Peek M., Flack J., Mclean M., Sweeting A., Kautzky-Willer A., Harreiter J., Gianatti E., Mohan V., Backman H. , Simmons D. on behalf of the TOBOGM consortium
OP 14 The impact of glycemia on the association between early GDM and pregnancy complications: Immanuel J., Cheung NW., Mohajeri M., Simmons DJ., Hague B., Teede H., Hibbert E., Nolan C., Peek M., Wong V., Flack J., Mclean M., Sweeting A., Kautzky-Willer A., Harreiter J., Gianatti E., Mohan V., Backman H., Simmons D. on behalf of the TOBOGM consortium.
OP 15 The FinnGeDi study: Pregnancy outcomes after early pregnancy oral glucose tolerance test screening of gestational diabetes: Keikkala E., Eteläinen S., Männistö T., Mustaniemi S., Kajantie E., Vääräsmäki M.
OP 16 A Critique of Defective Insulin Secretion and Insulin Sensitivity as a Precision Approach to Gestational Diabetes: Kusinski L, Jones D., Meek C.
OP 17 Identification and validation of gestational diabetes subgroups by data-driven cluster analysis: Wegener S. , Salvatori D., Kotzaeridi G., Herding A., Eppel F., Dressler-Steinbach I., Henrich W., Piersanti A., Morettini M., Tura A., Göbl C
17:00-17:45 ORAL PRESENTATIONS │ SESSION 4 (PG-DM I)
Chair: David McCance
OP 18 Fetal organ volume in pregnancies complicated by Type 1 Diabetes estimated by MRI: Rasmussen M., Clemmensen SK., Rathcke SL., Lindberg J., Christensen TT., Peters DA, Frøkjær JB., Sørensen A.
OP 19 T2* weighted placental MRI in type 1 diabetes pregnancies – a prospective study based on the FaPDi cohort.: Rathcke SL., Sinding MM., Christensen TT., Mulak-Król A., Uldbjerg N., Leenskjold S., Christiansen OB,Peters DA, Frøkjær JB, Sørensen A.
OP 20 Haemodynamic evaluation in pregnancies complicated by T1DM (Type 1 Diabetes Mellitus): differences in LGA (Large for Gestational Age) vs AGA (Appropriate for Gestational Age) newborns: Baggio B., Palazzo P., Cassé F., Ottanelli S., Angeli L., Zullino S., Serena C., Rambaldi MP., Simeone S., Bruscoli G., Valensise H., Mecacci F.
17:45-19:15
DPSG ANNUAL BUSINESS MEETING (only DPSG members)
Chair: Ewa Wender-Ozegowska
20:00-23:00
🍽 DINNER at Örebro castle
Saturday, Sept 7th, 2024
08:30-09:00 KEYNOTE LECTURE 3
Chair: Lene Ringholm
Katrien Benhalima : Randomised controlled trial of the MiniMed 780G system compared to standard insulin therapy in pregnant women with type 1 diabetes: the CRISTAL study
09:00-09:45 ORAL PRESENTATIONS │ SESSION 5 (DIABETES TECHNOLOGY)
Chair: Elisabeth R. Mathiesen
OP 21 Advanced hybrid closed loop compared to standard insulin therapy in type 1 diabetes during delivery and early postpartum: Beunen K., Van Wilder N, Ballaux D, Vanhaverbeke G., Taes Y., Aers XP., Nobels F., Van Huffel L, Marlier J., Lee D., Cuypers J., Preumont V., Siegelaar SE., Painter RC., Laenen A, Gillard P., Mathieu C., Benhalima K.
OP 22 Automated insulin delivery for the first 6 months postpartum: AiDAPT follow-up study: Lee TTM., Collett C., Bergford S.4, Hartnell S., Scott E., Lindsay RS., Hunt KF., McCance DR., Reynolds RM10, Wilinska ME, Sibayan J., Kollman C, Hovorka R., Murphy HR.
OP 23 Sensor-derived glycemic metrics in pregnant women with type 1 diabetes randomized to faster-acting insulin aspart or insulin aspart – A secondary analysis of the CopenFast trial: Søholm JC., Nørgaard SK., Nørgaard K., Clausen TD., Damm P., 1,2,3Elisabeth R. Mathiesen., Ringholm L.
09:45-10:15
☕ COFFEE BREAK
10:15-11:15 ORAL PRESENTATIONS │ SESSION 6 (PG-DM 2)
Chairs: Peter Damm, Angela Napoli
OP 24 Long-Term Neurobehavioral and Metabolic Outcomes in Offspring of Mothers with Diabetes During Pregnancy: A large, population-based cohort study in Ontario, Canada.: Feig D., Artani A., Asaf A., Li P., Booth G., Shah B.
OP25 Pregnancy outcomes in mothers with type 1 diabetes – trends during 26 years in Denmark : Gundersen TW., Knorr S., Ringholm L., Jensen DM, Damm P., Kragelund Nielsen K., Backman H., Lauenborg J., Mathiesen ER., Petersen AH., Skipper N., Kofoed-Enevoldsen A., Clausen TD.
OP26 Maternal HbA1c and BMI and risk of congenital malformations in type 1 diabetes: a cohort study: Thorius IH., Petersen J., Husemoen LN., Alibegovic AC., Gall MA., Damm P., Mathiesen ER.
OP27 Falling insulin requirements in pregnancies complicated by pregestational diabetes: Michelotti F., Dempsey A., Johnstone E., Myers J.
11:15-12:45 POSTER PRESENTATIONS │PARALLEL SESSION 2 – Theme IV│ GDM II and follow-up (Poster room I- Repsalen)
Chairs: Tine Clausen, Aoife Egan
PP 31 A study of the relationship between body composition and glucose intolerance in Japanese pregnant women: a single-centre prospective cohort study: Nakagawa T., Nagai Y., Tanaka Y., Sone M.
PP 32 Evaluating experiences of pregnant women at high risk of developing gestational diabetes who take part in intervention trials: a systematic review: Cakır GS., Bakhsh MA., Righton O., Quotah OF., White SL., Bell Z., Flynn AC.
PP 33 Patients with gestational diabetes mellitus may be treated in both early and late pregnancy, especially in patients with pre-pregnancy overweight: A cross-sectional study in Japan: Takemoto A., Nagai Y., Kawanabe S., Nakagawa T.,Matsumoto K., Hasagawa J., Suzuki N., Tanaka Y., Sone M.
PP 34 Withdrawn
PP 35 Normative data using continuous glucose monitoring system for glycemia in pregnancy at 24 to 32 weeks of gestation in Indian women defined as normal by IADPSG (International Association of Diabetes and Pregnancy Study Groups) criteria: Gupta Y., Garg V., Malhotra N., Sharma JB., Tandon N.
PP 36 Effectiveness of a culturally-appropriate lifestyle intervention programme, provided to women with GDM along with spouses after childbirth for improving the glycaemic status and/or weight of women: A Randomized Control Trial: Gupta Y., Ambekar S., Bhatla N., Tandon N.
PP 37 Glycemic data using Continuous glucose monitoring system for glycemia in pregnancy at 16 to 28 weeks of gestation in Indian women with Gestational Diabetes Mellitus as defined by IADPSG (International Association of Diabetes and Pregnancy Study Groups) criteria following metformin administration randomized to 2 arms – 500mg OD and 850mg OD: Sankeerth S, Rana A., Sharma A., Dhadwal V., Kalavani M., Sethi P., Tandon N., Gupta Y.
PP 38 One-year postpartum weight retention and glucose intolerance in women with prediabetes after gestational diabetes.: Raets L., Mievis V., Myngheer N., Maes T., De Block C., Bochanen N., Van Pottelbergh I., Abrams P., Vinck W., Leuridan L., Driessens S., Billen J., Matthys C., Laenen A., Bogaerts A., Mathieu C., Minschart C., Benhalima K.
PP 39 Artificial sweeteners in pregnancies complicated by gestational diabetes mellitus and offspring overweight.: Nielsen H., Gjørup E., Ovesen PG, Leth-Møller M.
PP 40 Metabolic and clinical outcomes with one abnormal value on Carpenter Coustan criteria: Scifres C., Davis E., Orris S., Costacou T., Lalama C., Abebe K., Catalano P.
PP 41 Fetal and newborn characteristics of offspring in relation to metabolic status in mothers with gestational diabetes mellitus: Højbjerre H, Knorr S., Madsen LR, Mortensen L., Sørensen LP., Thomsen HH, Ovesen PG., Fuglsang J., Kampmann U.
PP 42 Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteria: Andersson-Hall U., Kristiansson E., Zander M., Wallenius K., Sengpiel V., Holmäng A.
PP 43 Experiences of women with gestational diabetes mellitus (GDM) during pregnancy: an interpretative phenomenological analysis: Aalders J., Vinter CA., Jensen DM., Rothmann MJ.
PP 44 Timely GDM diagnosis and care in a local primary Hospital: call for improvement: Dozio N., Caretto A., Bradanini L., Ratti M., Consonni S., Mangone I., Manni M., Scavini M.
PP 45 Gestational diabetes in women of australian and culturally and linguistically diverse backgrounds: Grieger JA., Oxlad M.,Whitburn S.
PP 46 Facilitators and barriers to implement the WHO 2013 criteria for gestational diabetes – a mixed-methods study protocol: van der Wel AWT., Rademaker D., van Rijn BB., Painter RC.
PARALLEL SESSION 2
Theme V- Omics and public health (Poster room II- Wirensalen)
Chairs: Mireille van Poppel, Nicoletta Dozio
PP 47 Latent class analysis unveils discrete patterns of bile acid responses to an oral glucose challenge in pregnancy: Berger N., Dieberger A., Kirchhoff E., Obermayer-Pietsch B., Rodriguez-Blanco G., Herrmann M., Fluhr H., Jantscher-Krenn E.
PP 48 Early pregnancy hsCRP as a predictor of gestational diabetes: FinnGeDi case-control study: Lingaiah S., Mustaniemi S., Keikkala E., Kajantie E., Vääräsmäki M., and the FinnGeDi study group.
PP 49 Aerobic capacity, fat oxidation, body composition, and maximal muscular strength in relation to glucose metabolism 10 years after gestation diabetes mellitus: Kristiansson E., Holmäng A., Wallenius K., Börjesson O., Andersson-Hall U.
PP 50 The contribution of alpha- to beta-cell transdifferentiation to the plasticity of beta-cell mass: Diabetes versus pregnancy: Hill DJ., Arany E., Hahm J.
PP 51 Post-partum islet cell function: differences between subjects with and without gestational diabetes: Egan AM., Christie H., Mohan S., Vella A.
PP 52 Early gestation maternal metabolic factors influence the association between maternal physical activity and placental structure and oxidative stress markers: Zafaranieh S., Desoye G., Simmons D., van Poppel MNM., on behalf of DALI Core Investigator Group.
PP 53 Trophoblastic epithelial-mesenchymal transition with consecutive fibrosis:
a cause of reduced placental function in hyperglycemic pregnancies?: Hausdorf L., Große S., Rüllich A., Berndt A., Gaßler N., Groten T.
PP 54 Human Milk Oligosaccharides (HMOs) and their glucose / insulin interplay during lactation: Schönbacher L., Ramos-Román M., Fluhr H., Jantscher-Krenn E.
PP 55 Glucose homeostasis, metabolomics, and pregnancy outcomes after bariatric surgery: Deleus E., Geerts I., Devlieger R., Ceulemans D., Lannoo M., Van der Schueren B., Van Pottelbergh I., Van den Haute L., Lannoey E., Maes T., Myngheer N., Denys B., Bochanen N., Jochems L., Vandenberghe G., Marlier J., Morrens A., Debunne H, Loccufier A., Van den Bruel A., Benhalima K.
PP 56 Cost-effectiveness of oral medication strategy versus insulin for gestational diabetes mellitus: Broulikova HM., Rademaker D., van der Wel AWT., de Wit L., Duijnhoven RG., Voormolen DN., van der Post JAM2, Mol BW., Franx A., DeVries JH., van Rijn BB., Bosmans JE., Painter RC. and SUGAR-DIP study team
PP 57 Study protocol: Supporting Lifestyle Changes After Delivery – STELLA RCT: Mustaniemi S., Keikkala E., Hukkanen J., Savolainen M., Vääräsmäki M.
PP 58 Antenatal care and postpartum progression to diabetes in mothers with an elevated hba1c in the prediabetes range in early pregnancy: a 5-year observational study: Hughes R., Rowan J., Abraham E.
PP 59 The implementation of telemonitoring in the care of pregnant women with medically treated diabetes – evaluating the Sahlgrenska care model: Vikner P., Bogren M., Sengpiel V., Ringqvist AK., Linden K.
PP 60 Postpartum Recovery of Cognitive Function in Women with Type 1 Diabetes: A Longitudinal Study: Delmis J, Ivanisevic M.
PP 61 Continuous glucose monitoring metrics and suboptimal pregnancy outcomes in women with gestational diabetes: secondary analysis of the DiGest trial: Jones D., Thomson L., Kusinski LC., Beardsall K., Meek CL.
PP 62 Effects of maternal body mass index and gestational weight gain upon pregnancy outcomes in women with type 1 diabetes: a systematic review and meta-analysis: Atta N., Ezeoke A., Petry C., Kusinski LC., Meek CL.
PARALLELL SESSION 2
Theme VI │PG-DM and fetal growth (Poster room III- Behrnsalen)
Chairs: Marina Ivanisevic, Federico Mecacci
PP 63 The provision of reproductive healthcare for women living with type 2 diabetes in primary care: healthcare professionals’ experiences prior to the introduction of the PREPARED study intervention: Parsons J., Forbes A., Hopkins L., Famiglietti A., Chua KC., Hodgkinson A., Abiola O., Brackenridge A., Banerjee A., Chamley M., Hunt K., Murphy HR., Rogers H., Winkley K., Forde R., on behalf of the PREPARED study team.
PP 64 Effects of type 2 diabetes during pregnancy on fetal liver and brain volume and correlations with maternal and fetal metabolism: Leth-Møller M., Kofoed AS., Knorr S., Fuglsang J., Rathcke SL., Sørensen ANW., Ovesen PG., Kampmann U.
PP 65 Experiences of women living with Type 2 diabetes prior to and during pregnancy: a systematic review and thematic synthesis: Forde R., Dyer E., Flynn AC., Gunabalasingam S., Heslehurst N., Kyrka A., Lebrett R., Meek CL., Schoenaker DAJM., White SL., Hopkins L.
PP 66 Systematic review of factors influencing infant feeding practices in women with type 2 diabetes mellitus in pregnancy: Bakhsh MB., Bell Z., Righton O., Cakir GS., Quotah OF., Flynn AC., White SL.
PP 67 A bit of a rude awakening – women’s experiences of pregnancy with type 2 diabetes mellitus, a Swedish interview study: Linden K., Ericson K., Törnroos A., Bogren M.
PP 68 Interventions to optimise outcomes in women with type 2 diabetes in the pre-pregnancy, pregnancy and postpartum periods: a systematic review: Gunabalasingam S., Kyrka A., Heslehurst N., Forde R., Schoenaker DAJM., Meek CL., Hopkins L., Lebrett R., Flynn AC., White SL.
PP 69 To evaluate the effectiveness of enhanced behavioural intervention and use of technology (Continuous glucose monitoring) for improving pregnancy outcomes in women with type 2 Diabetes mellitus: A pilot three-arm parallel randomised controlled trial : Pal A., Malhotra N., Dadhwal V., Vikram N., Sethi P., Meena VP., Sachdeva A., Kalaivani M., Tandon N., Gupta Y.
PP 70 Fetal sex is a determinant of the association between maternal early pregnancy insulin resistance and offspring relative birth weight: Jokelainen M., Masalin S., Rönö K., Kautiainen H., Koistinen HA., Klemetti MM.
PP 71 Gestational weight gain according to IOM and pregnancy outcomes in women with gestational and pregestational diabetes : Mendoza LC., Xie X., Liu J., López A., García-Patterson A., Adelantado JM., López E., Corcoy R.
PP 72 Breastmilk of Mothers with Type 1 Diabetes. How does it compare to Non-diabetes Breastmilk and is it influenced by Maternal Glycemia? : Donovan LE., Reimer RA., Yamamoto JM., Lemieux P., Ho J., Feig D., Virtanen H., Crawford S., Murphy HR., Bell R.
PP 73 Correlation of nocturnal TIR and LGA using Continuous Glucose Monitoring in GDM pregnancies: Weschenfelder F., Scheiter LM., Heimann Y., Schleußner E., Groten T.
PP 74 Anthropometric and metabolic outcomes at birth and in 3-year-old offspring according to different diagnostic criteria for gestational diabetes mellitus – results from the Lifestyle in Pregnancy and Offspring trial: Luef BM., Stentebjerg LL., Tanvig M., Overgaard M., Jensen DM., Vinter CA.
PP 75 Long-term effects on neurocognitive development, mental health and stress regulation of offspring from pregnancies with gestational diabetes – follow-up of offspring 20-30 years later: Weschenfelder F., Mankewitz J., Heimann Y., Schleußner E., Groten T.
PP 76 Impact of maternal physical activity and neonatal estimated fat mass on BMI in offspring in the 1st year of life: insights from the DALI study: Kames M., Tanvig M., Simmons D., Desoye G., Devlieger R., Corcoy R., Adelantado JM., Dunne F., Harreiter J., Kautzky-Willer A., Damm P., Mathiesen ER., Jensen DM., Andersen LL., Lapolla A., Dalfra MG., Bertolotto A., Wender-Ozegowska E., Zawiejska A., Hill D., Snoek FJ., Jelsma JGM, van Poppel MNM.
PP 77 The influence of maternal vitamin D status and calcium intake in obese pregnant women on offspring bone mineral density (BMD) at birth: Jepsen AA., Renault KM., Brøns C., Hansen EK., Schmidt P., Mølgaard C.
PP 78 FeDiLiS: Fetal growth Diabetes Lipid Study – work in progress: Wegener S., Dressler-Steinbach I., Scholz A., Kehler S., Fauzan R., Mahnke E., Ramsauer B., Henrich W., Schaefer- Graf U.
12:45-14:00
🍽 LUNCH BREAK
14:00-15:00 ORAL PRESENTATIONS │ SESSION 7 (PUBLIC HEALTH)
Chairs: Jenny Myers, Marja Vääräsmäki
OP 28 Maternal and neonatal outcomes among women with type 1 diabetes and type 2 diabetes, in relation to women without diagnosed hyperglycemia, in Sweden 2015–2020 – a retrospective registry study of the DIP-Swe project: Ignell C., Nilsson G., Hoff E., Lindegren L., Nilsson C.
OP 29 The choice of growth standard affects the outcomes when assessing large for gestational age in research studies – Evidence from the CDC4G trial: Grass S., de Brun M., Sengpiel V., Simmons D., Magnuson A., Persson M., Montgomery S., Patil S., Berntorp K., Wennerholm UB., Strevens H., Hildén K., Wikström AK., Backman H., Ahlsson F.
OP 30 Increasing maternal overweight and obesity and persisting high rates of fetal macrosomia in type 1 diabetic pregnancies at Helsinki University Hospital during 1989-2022: Lundberg M., Heikkinen-Eloranta J., Rautava S., Jääskeläinen T., Klemetti MM.
OP 31 A Population-based Study Examining Incidence and Outcomes of Diabetes in TeenagePregnancy.: Christie HE., Mohan S., Vella A., Creo AL., Egan AM.
OP 32 Long-term cardio-metabolic profile after gestational diabetes mellitus: Results from the Odense GDM follow-up study – OGFUS.: Hallig SJ., Alders J., Christensen MH., Andersen MS., Mortensen KSB., Vinter CA., Højlund K., Jensen DM., Overgaard M.
OP 33 Sustained Reduction of Subclinical Inflammation in the years after Breastfeeding: A Potential Mediator of the Cardioprotective Effect of Lactation in Women. : Boelling M., Pu J., Hanley AJ., Connelly PW., Sermer M., Zinman B., Retnakaran R.
15:30-15:45 JOHN STOWERS POSTER AWARDS
Chair: Ewa Wender-Ożegowska
Recipients for 1st, 2nd and 3rd highest scored abstracts
15:45-16:00 Acknowledgements & Adjournment
16:15-17:15 Walkingtour in Örebro City – FREE TIME
19:00-late
🍽 DINNER and dance at Elite Stora Hotellet
Presentation of Young Investigator Travel Awards
Örebro Concert Hall
Fabriksgatan 2 A
702 10 Örebro